UK court rules against clinic in puberty blocking drugs case
Added 12-01-20 01:03:01pm EST - “Britain's High Court ruled Tuesday that children under 16 years old who are considering gender reassignment are unlikely to be able to give informed consent to medical treatment involving drugs that delay puberty.” - Washingtontimes.com
CLICK TO SHARE
LONDON (AP) - Britain’s High Court ruled Tuesday that children under 16 years old who are considering gender reassignment are unlikely to be able to give informed consent to medical treatment involving drugs that delay puberty.
The ruling said that because of the experimental nature of the drugs, clinics should seek court authorization before starting such treatment, even in cases of teens aged 16 or over.
The case was brought by two claimants against a National Health Service trust that runs the U.K.’s main gender identity development service for children. One of the claimants, who was prescribed hormone blockers at 16, argued that the clinic should have challenged her more over her decision to transition to a male.
TOP STORIES Biden weighs Rahm Emanuel for transportation secretary Fellow Republicans file articles of impeachment against Ohio governor $908 billion: Centrists propose bipartisan breakthrough for coronavirus relief
Tuesday’s ruling will “protect vulnerable young people,” said Keira Bell, who is now 23 and has stopped taking cross-sex hormones. She added that she was “delighted to see that common sense has prevailed.”
If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.
CLICK TO SHARE